| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K02251932 |
| PharmacoGx | BRD-K02251932 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TMEM31 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | C14orf159 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | SNRNP48 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | CDK18 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | RPL8 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | MED30 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | LRP5L | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | POU2F1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
| mRNA | CTD-2313N18.7 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | FAM126B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0004 |
